News

North American Cystic Fibrosis Conference will stand in few days. Rheonova team would be glad to meet you there and present its Poster n°529 “RHEOLOGICAL SIGNATURE OF INDUCTION ON CF SPUTUM: SPONTANEOUS VERSUS HYPERTONIC SALINE VERSUS...

Following an intensive selection process through a dedicated European-Canadian jury, thirteen European companies are laureates of the 2019 edition of the GoGlobal Canada program and will benefit from a unique gateway to Canada. Click here for the full press...

Winner of the "Concours Innovation", Rheonova will continue the clinical validation for a diagnostic test for Cystic Fibrosis. A financial aid of 352.000 € for the MucoCF project using the medical device Rheomuco® For the press release, click...

Rheonova and the French Laboratory for Rheology & Process are proud to present  the LabCom «MUCUS», a joint laboratory focused on new diagnostic and monitoring strategies for chronic pulmonary diseases. A 300K€ funding to sustain research partnership between Rheonova...

Jeremy Patarin is looking forward to discussing the importance of mucus rheology during his poster presentation on the 18th of September starting 14h45 in room 7.2D. The 28th ERS international congress is the biggest meeting in respiratory medicine which makes it the...

Rheonova looks forward to seeing you at the 41st Conference which will take place in Belgrade, Serbia, 6-9 June 2018. The conference will gather leading CF caregivers and researchers. The three-day program includes seminars, round table talks, Meet the Expert sessions...

On March 11-12, 2018, Rheonova will be present at the MT-CONNECT in Nuremberg, Germany. This major event for the medical technology sector will take place at Exhibition Centre Nuremberg. Co-organized by the Bavarian Government and co-sponsors by EIT Health HQ – this...

Rheonova will be present at the 3rd Francophone Day of Cystic Fibrosis, Lyon, April 5th-7th 2018. Every 2 years, patients and health professionals meet together during this event organized by Vaincre la Mucoviscidose and by the French Society of Cystic Fibrosis (SFM)....

You are working on respiratory diseases such as cystic fibrosis, COPD or asthma? Demonstrations of Rheomuco are regularly organized on our site, on the sites of our partners or on your premises. Contact us to learn more about Rheomuco's...

On January 26, 2018, come to listen to Jeremy Patarin’s presentation, CEO of Rheonova, on the rheology of bronchial secretions as a tool for monitoring cystic fibrosis and evaluating the efficacy of new treatments, as well as the evaluation of the rheological...

Rheonova will participate at the Biofit business convention that will be held in Strasbourg on 28 and 29 November 2017. We will have the opportunity to present our laboratory equipment, Rheomuco, allowing the measurement of the viscoelastic properties of...

Respiratory diseases will become the third leading cause of death in 2020 according to WHO, due to pollution and tobacco. The Rheomuco device developed by Rheonova is aimed at researchers and health professionals. It helps the evaluation of treatments and the...